Thus, we aimed to identify and validate the predictive role of EV PD-L1 dynamics in patients with advanced/metastatic NSCLC treated with ICIs compared to the standard-of-care tissue PD-L1. The gene discussed is CD274; the disease is non-small cell lung carcinoma.